Top

Cialis and Increased Risks for Skin Cancer

Posted on 08/12/2016Back

Seven separate complaints have recently been filed by Cialis users against Eli Lilly regarding the development of melanoma – the most deadly form of skin cancer – while using the medication. The Indianapolis Business Journal reports that “several major medical journals” have published studies linking Cialis’s PDE5 inhibitor to melanoma. One study in particular cited by these plaintiffs suggests that PDE5 inhibitors lead to increased tumor growth. This study did not, however, mention Cialis by name.

Cialis is not the first erectile dysfunction medication that has been linked to the development of skin cancer. In 2014, the Journal of the American Medical Association published results from a study suggesting sildenafil, the active ingredient in Viagra, posed “an increased risk of developing melanoma.” As a result, a number of individual and class action lawsuits have been filed against Pfizer by men who have developed skin cancer while, or shortly after, taking Viagra.

In suits involving both of these medications, plaintiffs claim the companies knew about increased risks and failed to warn against or even mention the dangers. Should these claims be found true, they would join a long list of medications pushed by pharmaceutical companies despite known and potentially deadly dangers. If you or a loved one falls victim to one of these medications, the dangerous drug attorneys at GoldenbergLaw can help you get justice.

Please contact us online or call 612-436-5026 to learn more. The medication injury attorneys at GoldenbergLaw serve victims of irresponsible pharmaceutical companies.

Category Dangerous Drugs